229 related articles for article (PubMed ID: 16202666)
1. Relationship between glycosylated haemoglobin and mean plasma glucose concentration in cystic fibrosis.
Brennan AL; Gyi KM; Wood DM; Hodson ME; Geddes DM; Baker EH
J Cyst Fibros; 2006 Jan; 5(1):27-31. PubMed ID: 16202666
[TBL] [Abstract][Full Text] [Related]
2. No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes.
Godbout A; Hammana I; Potvin S; Mainville D; Rakel A; Berthiaume Y; Chiasson JL; Coderre L; Rabasa-Lhoret R
Diabetes Metab; 2008 Dec; 34(6 Pt 1):568-73. PubMed ID: 18922724
[TBL] [Abstract][Full Text] [Related]
3. Does glucose variability influence the relationship between mean plasma glucose and HbA1c levels in type 1 and type 2 diabetic patients?
Kuenen JC; Borg R; Kuik DJ; Zheng H; Schoenfeld D; Diamant M; Nathan DM; Heine RJ;
Diabetes Care; 2011 Aug; 34(8):1843-7. PubMed ID: 21700921
[TBL] [Abstract][Full Text] [Related]
4. A simple way to estimate mean plasma glucose and to identify Type 2 diabetic subjects with poor glycaemic control when a standardized HbA1c assay is not available.
Ozmen S; Cil T; Atay AE; Tuzcu AK; Bahceci M
Diabet Med; 2006 Oct; 23(10):1151-4. PubMed ID: 16978383
[TBL] [Abstract][Full Text] [Related]
5. Sputum glucose and glycemic control in cystic fibrosis-related diabetes: a cross-sectional study.
Van Sambeek L; Cowley ES; Newman DK; Kato R
PLoS One; 2015; 10(3):e0119938. PubMed ID: 25803537
[TBL] [Abstract][Full Text] [Related]
6. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial.
Rohlfing CL; Wiedmeyer HM; Little RR; England JD; Tennill A; Goldstein DE
Diabetes Care; 2002 Feb; 25(2):275-8. PubMed ID: 11815495
[TBL] [Abstract][Full Text] [Related]
7. Variability in the relationship between mean plasma glucose and HbA1c: implications for the assessment of glycemic control.
Kilpatrick ES; Rigby AS; Atkin SL
Clin Chem; 2007 May; 53(5):897-901. PubMed ID: 17384010
[TBL] [Abstract][Full Text] [Related]
8. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data.
Pickup JC; Freeman SC; Sutton AJ
BMJ; 2011 Jul; 343():d3805. PubMed ID: 21737469
[TBL] [Abstract][Full Text] [Related]
9. Relationship between glycated haemoglobin levels and mean glucose levels over time.
Nathan DM; Turgeon H; Regan S
Diabetologia; 2007 Nov; 50(11):2239-44. PubMed ID: 17851648
[TBL] [Abstract][Full Text] [Related]
10. Relationship between mean blood glucose and glycated haemoglobin in Type 2 diabetic patients.
Makris K; Spanou L; Rambaouni-Antoneli A; Koniari K; Drakopoulos I; Rizos D; Haliassos A
Diabet Med; 2008 Feb; 25(2):174-8. PubMed ID: 18290858
[TBL] [Abstract][Full Text] [Related]
11. Fasting plasma glucose 6-12 weeks after starting insulin glargine predicts likelihood of treatment success: a pooled analysis.
Karl D; Zhou R; Vlajnic A; Riddle M
Diabet Med; 2012 Jul; 29(7):933-6. PubMed ID: 22413808
[TBL] [Abstract][Full Text] [Related]
12. Conventional measures underestimate glycaemia in cystic fibrosis patients.
Dobson L; Sheldon CD; Hattersley AT
Diabet Med; 2004 Jul; 21(7):691-6. PubMed ID: 15209760
[TBL] [Abstract][Full Text] [Related]
13. The impact of blood glucose and HbA(1c) goals on glycaemic control in children and adolescents with Type 1 diabetes.
Boot M; Volkening LK; Butler DA; Laffel LM
Diabet Med; 2013 Mar; 30(3):333-7. PubMed ID: 23190135
[TBL] [Abstract][Full Text] [Related]
14. Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatment.
Konya J; Ng JM; Cox H; Cooke M; Lewis N; Bhandari S; Atkin SL; Kilpatrick ES
Diabet Med; 2013 Oct; 30(10):1250-4. PubMed ID: 23758176
[TBL] [Abstract][Full Text] [Related]
15. The relationship between self-monitored blood glucose values and glycated haemoglobin in insulin-treated patients with Type 2 diabetes.
Sarwat S; Ilag LL; Carey MA; Shrom DS; Heine RJ
Diabet Med; 2010 May; 27(5):589-92. PubMed ID: 20536957
[TBL] [Abstract][Full Text] [Related]
16. The glucose area under the profiles obtained with continuous glucose monitoring system relationships with HbA(lc) in pediatric type 1 diabetic patients.
Salardi S; Zucchini S; Santoni R; Ragni L; Gualandi S; Cicognani A; Cacciari E
Diabetes Care; 2002 Oct; 25(10):1840-4. PubMed ID: 12351488
[TBL] [Abstract][Full Text] [Related]
17. Hemoglobin Glycosylation Index is not related with blood glucose.
Merino-Torres JF; Fajardo-Montañana C; Ferrer-García JC; Piñón-Sellés F
J Diabetes Complications; 2003; 17(5):249-53. PubMed ID: 12954152
[TBL] [Abstract][Full Text] [Related]
18. Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability.
Pickup JC; Kidd J; Burmiston S; Yemane N
Diabetes Metab Res Rev; 2006; 22(3):232-7. PubMed ID: 16389648
[TBL] [Abstract][Full Text] [Related]
19. Predictors of glycaemic control in patients with Type 1 diabetes commencing continuous subcutaneous insulin infusion therapy.
Shalitin S; Gil M; Nimri R; de Vries L; Gavan MY; Phillip M
Diabet Med; 2010 Mar; 27(3):339-47. PubMed ID: 20536498
[TBL] [Abstract][Full Text] [Related]
20. Hemoglobin A1c and mean glucose in patients with type 1 diabetes: analysis of data from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial.
; Wilson DM; Xing D; Beck RW; Block J; Bode B; Fox LA; Hirsch I; Kollman C; Laffel L; Ruedy KJ; Steffes M; Tamborlane WV
Diabetes Care; 2011 Mar; 34(3):540-4. PubMed ID: 21266647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
